2026 Diarmaid Hughes: Biology and Biochemistry Researcher – H-Index, Publications & Awards

D-Index & Metrics

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	56	14170	13033	211	187	204	18466

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Biology and Biochemistry

14170

13033

211

187

204

18466

Biology and Biochemistry

D-Index

Citations

18466

World Ranking

14170

National Ranking

211

Overview

Diarmaid Hughes is affiliated with Uppsala University in Sweden and conducts research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields including Molecular Medicine, Cardiology and Cardiovascular Medicine, Molecular Biology, Genetics, and Pharmacology.

The scientific interests of Diarmaid Hughes focus largely on Antibiotic Resistance in Bacteria, with additional attention to Antibiotics Pharmacokinetics and Efficacy, Bacterial Genetics and Biotechnology, Evolution and Genetic Dynamics, Cardiac Imaging and Diagnostics, Cardiovascular Function and Risk Factors, and Cancer therapeutics and mechanisms.

Frequent co-authors collaborating with Diarmaid Hughes include:

Sha Cao
Douglas L. Huseby
Gerrit Brandis
Carina Vingsbo Lundberg
Jon Hansen

Their recent publications illustrate a focus on bacterial infections, antimicrobial development, and evolutionary dynamics:

"Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections", 2021, Proceedings of the National Academy of Sciences
"Population Bottlenecks Strongly Influence the Evolutionary Trajectory to Fluoroquinolone Resistance in Escherichia coli", 2020, Molecular Biology and Evolution
"Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa", 2023, Journal of Medicinal Chemistry
"Model-Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin", 2020, Clinical Pharmacology & Therapeutics
"Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice", 2020, Clinical Microbiology and Infection

Key venues where Diarmaid Hughes frequently publishes include:

Journal of Antimicrobial Chemotherapy
Journal of the American College of Cardiology
Proceedings of the National Academy of Sciences
Molecular Biology and Evolution
European Heart Journal

Best Publications

Antibiotic resistance and its cost: is it possible to reverse resistance?

Dan I. Andersson;Diarmaid Hughes

2772
Citations
Selection of resistant bacteria at very low antibiotic concentrations.

Erik Gullberg;Sha Cao;Otto G. Berg;Carolina Ilbäck

1860
Citations
Microbiological effects of sublethal levels of antibiotics

Dan I. Andersson;Diarmaid Hughes

1855
Citations
Mechanisms and consequences of bacterial resistance to antimicrobial peptides

Dan I. Andersson;Diarmaid Hughes;Jessica Z. Kubicek-Sutherland

764
Citations
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance.

J Björkman;I Nagaev;O G Berg;Diarmaid Hughes

603
Citations
Persistence of antibiotic resistance in bacterial populations

Dan I. Andersson;Diarmaid Hughes

539
Citations
Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections

Patricia Komp Lindgren;Åsa Karlsson;Diarmaid Hughes

467
Citations
Evolution of antibiotic resistance at non-lethal drug concentrations.

Dan I. Andersson;Diarmaid Hughes

441
Citations
Virulence of antibiotic-resistant Salmonella typhimurium

Johanna Björkman;Diarmaid Hughes;Dan I. Andersson

431
Citations
Interplay in the selection of fluoroquinolone resistance and bacterial fitness.

Linda L. Marcusson;Niels Frimodt-Møller;Diarmaid Hughes

390
Citations
Gene Amplification and Adaptive Evolution in Bacteria

Dan I Andersson;Diarmaid Hughes

341
Citations
Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus

Ivan Nagaev;Johanna Björkman;Dan I Andersson;Diarmaid Hughes

315
Citations
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms

Diarmaid Hughes;Dan I. Andersson

247
Citations
Muller's ratchet decreases fitness of a DNA-based microbe

Dan I. Andersson;Diarmaid Hughes

218
Citations
Evolutionary Trajectories to Antibiotic Resistance

Diarmaid Hughes;Dan I. Andersson

213
Citations
Establishment of a Superficial Skin Infection Model in Mice by Using Staphylococcus aureus and Streptococcus pyogenes

Elisabeth Kugelberg;Tobias Norström;Thomas K. Petersen;Tore Duvold

205
Citations
Fitness‐compensatory mutations in rifampicin‐resistant RNA polymerase

Gerrit Brandis;Marie Wrande;Lars Liljas;Diarmaid Hughes

204
Citations
Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site.

Martin Laurberg;Ole Kristensen;Kirill Martemyanov;Anatoly T Gudkov

187
Citations
Selection of resistance at lethal and non-lethal antibiotic concentrations

Diarmaid Hughes;Dan I Andersson

179
Citations
Limitations of translational accuracy

CG Kurland;Diarmaid Hughes;M. Ehrenberg

178
Citations